Payment overview · 2025
General Payments
$88.19
5 reported records · 3 companies
Healthcare provider profile · identity verified
Scott Smith, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · KEARNEY, NE · NPI 1205819158
Verified facts
What the public records show
CMS Open Payments records show Scott Smith, M.D. received $88.19 in general payments during 2025 across 5 reported records.
PFIZER INC. accounted for 65.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 94 claims for Synthroid by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 144 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 38 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Trulicity by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 253 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| PFIZER INC. | Unresolved — no canonical attribution shown | $57.29 | 65.0% | 3 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $16.60 | 18.8% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $14.30 | 16.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $88.19 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $57.29 | 3 | 2025 |
Source payment records
|
|||||
| COMIRNATY Normalized: comirnaty |
Biological | PFIZER INC. | $57.29 | 3 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $57.29 | 3 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $16.60 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $16.60 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $14.30 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 38 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
14 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
94 | 25 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
144 | 24 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
38 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
23 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
253 | 35 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
23 | 23 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 1430 | 239 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1180 | 243 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1150 | 209 |
| Gabapentin | Gabapentin | 821 | 121 |
| Amlodipine Besylate | Amlodipine Besylate | 795 | 153 |
| Omeprazole | Omeprazole | 598 | 118 |
| Potassium Chloride | Potassium Chloride | 592 | 111 |
| Simvastatin | Simvastatin | 545 | 112 |
| Tamsulosin Hcl | Tamsulosin Hcl | 536 | 103 |
| Memantine Hcl | Memantine Hcl | 514 | 67 |
| Lisinopril | Lisinopril | 497 | 103 |
| Meloxicam | Meloxicam | 476 | 98 |
| Tramadol Hcl | Tramadol Hcl | 474 | 92 |
| Glimepiride | Glimepiride | 458 | 80 |
| Metoprolol Succinate | Metoprolol Succinate | 454 | 101 |
| Furosemide | Furosemide | 440 | 74 |
| Metformin Hcl | Metformin Hcl | 435 | 89 |
| Allopurinol | Allopurinol | 402 | 69 |
| Escitalopram Oxalate | Escitalopram Oxalate | 394 | 65 |
| Prednisone | Prednisone | 379 | 120 |
| Losartan Potassium | Losartan Potassium | 363 | 69 |
| Hydrochlorothiazide | Hydrochlorothiazide | 317 | 67 |
| Montelukast Sodium | Montelukast Sodium | 307 | 56 |
| Metoprolol Tartrate | Metoprolol Tartrate | 280 | 52 |
| Donepezil Hcl | Donepezil Hcl | 279 | 43 |
| Bumetanide | Bumetanide | 268 | 55 |
| Eliquis | Apixaban | 253 | 35 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 252 | 50 |
| Pregabalin | Pregabalin | 245 | 36 |
| Trazodone Hcl | Trazodone Hcl | 242 | 49 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 233 | 55 |
| Buspirone Hcl | Buspirone Hcl | 224 | 38 |
| Carvedilol | Carvedilol | 222 | 44 |
| Clopidogrel | Clopidogrel Bisulfate | 222 | 51 |
| Xarelto | Rivaroxaban | 187 | 31 |
| Irbesartan | Irbesartan | 185 | 33 |
| Pravastatin Sodium | Pravastatin Sodium | 175 | 43 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 173 | 26 |
| Duloxetine Hcl | Duloxetine Hcl | 172 | 26 |
| Citalopram Hbr | Citalopram Hydrobromide | 168 | 30 |
| Mirtazapine | Mirtazapine | 168 | 26 |
| Sertraline Hcl | Sertraline Hcl | 168 | 21 |
| Clonazepam | Clonazepam | 162 | 32 |
| Oxybutynin Chloride | Oxybutynin Chloride | 147 | 18 |
| Chlorthalidone | Chlorthalidone | 145 | 33 |
| Jardiance | Empagliflozin | 144 | 24 |
| Myrbetriq | Mirabegron | 138 | 20 |
| Spironolactone | Spironolactone | 132 | 27 |
| Zolpidem Tartrate | Zolpidem Tartrate | 128 | 30 |
| Levofloxacin | Levofloxacin | 126 | 103 |
| Amitriptyline Hcl | Amitriptyline Hcl | 121 | 29 |
| Methylprednisolone | Methylprednisolone | 118 | 99 |
| Warfarin Sodium | Warfarin Sodium | 117 | 20 |
| Aripiprazole | Aripiprazole | 107 | 15 |
| Dicyclomine Hcl | Dicyclomine Hcl | 106 | 18 |
| Lorazepam | Lorazepam | 105 | 20 |
| Repatha Sureclick | Evolocumab | 105 | 13 |
| Celecoxib | Celecoxib | 102 | 27 |
| Olanzapine | Olanzapine | 102 | 15 |
| Doxycycline Hyclate | Doxycycline Hyclate | 97 | 60 |
| Midodrine Hcl | Midodrine Hcl | 95 | 21 |
| Synthroid | Levothyroxine Sodium | 94 | 25 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 93 | 14 |
| Metoclopramide Hcl | Metoclopramide Hcl | 88 | 15 |
| Azithromycin | Azithromycin | 86 | 67 |
| Nebivolol Hcl | Nebivolol Hcl | 84 | 16 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 83 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 82 | 11 |
| Atenolol | Atenolol | 81 | 17 |
| Bupropion Xl | Bupropion Hcl | 79 | 15 |
| Pioglitazone Hcl | Pioglitazone Hcl | 78 | suppressed |
| Primidone | Primidone | 78 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 77 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 76 | 22 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 74 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 74 | 29 |
| Ranolazine Er | Ranolazine | 74 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 72 | 13 |
| Enalapril Maleate | Enalapril Maleate | 71 | 13 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 70 | 59 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 68 | 24 |
| Cefuroxime | Cefuroxime Axetil | 67 | 31 |
| Ezetimibe | Ezetimibe | 67 | 17 |
| Famotidine | Famotidine | 67 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 67 | 23 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 67 | 15 |
| Memantine Hcl Er | Memantine Hcl | 66 | suppressed |
| Alprazolam | Alprazolam | 65 | 14 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 65 | 12 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 64 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 63 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 62 | 12 |
| Sucralfate | Sucralfate | 61 | 13 |
| Benazepril Hcl | Benazepril Hcl | 59 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 59 | 25 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 58 | suppressed |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 57 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 56 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 56 | 14 |
| Ramipril | Ramipril | 56 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 56 | suppressed |
| Dutasteride | Dutasteride | 54 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 53 | 28 |
| Cefdinir | Cefdinir | 52 | 48 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 52 | 45 |
| Lamotrigine | Lamotrigine | 48 | suppressed |
| Metolazone | Metolazone | 48 | suppressed |
| Novolog Flexpen | Insulin Aspart | 48 | 11 |
| Amoxicillin | Amoxicillin | 47 | 17 |
| Glipizide Er | Glipizide | 46 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 46 | 22 |
| Methotrexate | Methotrexate Sodium | 45 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 45 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 44 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 43 | suppressed |
| Ozempic | Semaglutide | 43 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 43 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 42 | 42 |
| Fluoxetine Hcl | Fluoxetine Hcl | 42 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 41 | suppressed |
| Valsartan | Valsartan | 41 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 40 | suppressed |
| Estradiol | Estradiol | 40 | suppressed |
| Glipizide | Glipizide | 40 | suppressed |
| Topiramate | Topiramate | 40 | 15 |
| Levemir Flexpen | Insulin Detemir | 39 | 11 |
| Fluconazole | Fluconazole | 38 | 16 |
| Hydrocortisone | Hydrocortisone | 38 | suppressed |
| Mounjaro | Tirzepatide | 38 | suppressed |
| Levetiracetam | Levetiracetam | 37 | suppressed |
| Lovastatin | Lovastatin | 35 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 35 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 34 | 28 |
| Quetiapine Fumarate | Quetiapine Fumarate | 33 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 31 | suppressed |
| Fenofibrate | Fenofibrate | 31 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 31 | suppressed |
| Finasteride | Finasteride | 31 | suppressed |
| Temazepam | Temazepam | 31 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 30 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 30 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 28 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 27 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 27 | suppressed |
| Movantik | Naloxegol Oxalate | 27 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 27 | 14 |
| Entresto | Sacubitril/Valsartan | 26 | suppressed |
| Nitroglycerin | Nitroglycerin | 26 | 18 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 26 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 26 | suppressed |
| Anastrozole | Anastrozole | 25 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 25 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 25 | suppressed |
| Risperidone | Risperidone | 25 | suppressed |
| Baclofen | Baclofen | 24 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 24 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 23 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 23 | suppressed |
| Naproxen | Naproxen | 23 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 23 | 23 |
| Sotalol | Sotalol Hcl | 23 | suppressed |
| Trulicity | Dulaglutide | 23 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 22 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 22 | suppressed |
| Nystatin | Nystatin | 22 | 14 |
| Verapamil Er | Verapamil Hcl | 22 | suppressed |
| Methocarbamol | Methocarbamol | 21 | suppressed |
| Nifedipine Er | Nifedipine | 21 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 21 | suppressed |
| Torsemide | Torsemide | 21 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 20 | suppressed |
| Azathioprine | Azathioprine | 20 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 20 | suppressed |
| Latanoprost | Latanoprost | 20 | suppressed |
| Loperamide | Loperamide Hcl | 20 | suppressed |
| Nyamyc | Nystatin | 20 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 20 | suppressed |
| Ibuprofen | Ibuprofen | 19 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 19 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 19 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 19 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 18 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 17 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 17 | suppressed |
| Diazepam | Diazepam | 17 | suppressed |
| Linzess | Linaclotide | 17 | suppressed |
| Mirabegron Er | Mirabegron | 17 | suppressed |
| Procto-Med Hc | Hydrocortisone | 17 | suppressed |
| Clonidine | Clonidine | 16 | suppressed |
| Erythromycin Ethylsuccinate | Erythromycin Ethylsuccinate | 16 | suppressed |
| Ondansetron Odt | Ondansetron | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | 12 |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 15 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 15 | suppressed |
| Phenobarbital | Phenobarbital | 15 | suppressed |
| Repatha Syringe | Evolocumab | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | 14 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Creon | Lipase/Protease/Amylase | 14 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 14 | suppressed |
| Klor-Con M20 | Potassium Chloride | 14 | suppressed |
| Praluent Pen | Alirocumab | 14 | suppressed |
| Ropinirole Er | Ropinirole Hcl | 14 | suppressed |
| Telmisartan | Telmisartan | 14 | suppressed |
| Testosterone | Testosterone | 14 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 13 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 13 | suppressed |
| Euthyrox | Levothyroxine Sodium | 13 | suppressed |
| Fluvastatin Er | Fluvastatin Sodium | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Premarin | Estrogens, Conjugated | 13 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Balsalazide Disodium | Balsalazide Disodium | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 12 | suppressed |
| Cefadroxil | Cefadroxil | 12 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 12 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Trimethoprim | Trimethoprim | 12 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Zetia | Ezetimibe | 12 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 11 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 11 | suppressed |
| Febuxostat | Febuxostat | 11 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 11 | suppressed |
| Januvia | Sitagliptin Phosphate | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 11 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 11 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 11 | suppressed |
| Restasis | Cyclosporine | 11 | suppressed |
| Tobramycin | Tobramycin | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $88.19 · 5 records | PFIZER INC. | ABRYSVO, COMIRNATY, MOUNJARO, PREVNAR 20, QULIPTA, UBRELVY | 8 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Mounjaro play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error